Fulcrum Therapeutics, Inc. ( FULC ) Q1 2026 Earnings Call April 27, 2026 8:00 AM EDT Company Participants Alexander Sapir - CEO, President & Director Alan Musso - Chief Financial Officer Iain Fraser - Senior Vice President of Early Development Conference Call Participants Joseph Schwartz - Leerink Partners LLC, Research Division Anupam Rama - JPMorgan Chase & Co, Research Division Kristen Kluska - Cantor Fitzgerald & Co., Research Division Corinne Jenkins - Goldman Sachs Group, Inc., Research Division James Condulis - Stifel, Nicolaus & Company, Incorporated, Research Division Matthew Biegler - Oppenheimer & Co. Inc., Research Division Gregory Renza - Truist Securities, Inc., Research Division Presentation Operator Good morning, and welcome to Fulcrum Therapeutics First Quarter 2026 Financial Results and Business Update Conference Call.…